celecoxib has been researched along with fura-2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HT; Chen, JS; Chen, WC; Ho, CM; Hsu, SS; Huang, JK; Jan, CR; Jiann, BP; Lin, KL; Lu, YC; Wang, JL | 1 |
| Chang, HT; Chen, IS; Cheng, JS; Chou, CT; Hsu, SS; Jan, CR; Kuo, CC; Liao, WC; Lin, KL; Liu, SI; Lu, YC; Tsai, JY; Wang, JL | 1 |
2 other study(ies) available for celecoxib and fura-2
| Article | Year |
|---|---|
Effect of celecoxib on Ca2+ movement and cell proliferation in human osteoblasts.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium; Calcium Signaling; Celecoxib; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Fura-2; Humans; Osteoblasts; Pyrazoles; Sulfonamides; Tetrazolium Salts; Type C Phospholipases | 2004 |
Effect of celecoxib on Ca(2+) handling and viability in human prostate cancer cells (PC3).
Topics: Calcium; Calcium Channels, L-Type; Celecoxib; Cell Death; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Fluorescent Dyes; Fura-2; Humans; Male; Phospholipases A2; Prostatic Neoplasms; Pyrazoles; Sulfonamides | 2012 |